Virtual consulting · Worldwide
NeuciteConsultingRequest a quote

Grant writing services for life sciences R&D funding

We draft, critique and tighten R&D funding applications, such as SBIR/STTR, Horizon Europe and national programs, against each call's scoring criteria. You stay the applicant and author of record.

Funding applications built on the science and read like a reviewer would

Our grant writing services support biotech, medical device, materials and nutraceutical companies, and the research organizations they partner with, when they apply for non-dilutive R&D funding. Reviewers look for a clear problem, a credible plan, a capable team and a believable route to use. Strong projects often lose points because the application hides one of these.

We support applications to schemes such as the US SBIR and STTR programs, Horizon Europe calls, national innovation funding programs and translational grants from agencies and foundations. Program rules and budgets change, so we always work from the current call text. Its evaluation criteria shape the narrative, work packages, milestones and risk register.

Our edge is technical depth. We read your data the way a scientific reviewer will, spot claims the evidence cannot yet carry, and tighten the feasibility case. Where biomaterials, polymers, hydrogels, sterilization or formulation sit at the center of a project, we test assumptions that generalist writers often accept on trust.

You remain the applicant and the author of record. We draft, edit and critique alongside your team, and we always follow each funder's rules on outside support and AI-assisted drafting. We never promise an award or quote success rates. Funding decisions rest with the agency, its reviewers and its available budget.

What our grant writing services cover

Choose the full application or only the sections where you need support.

01

Call fit and eligibility check

We read the call text, eligibility rules and evaluation criteria against your project. You get a short note on fit, partner requirements, budget limits and the readiness level or phase the scheme expects.

02

Technical narrative and objectives

We structure the problem, objectives, innovation and approach so reviewers find each criterion quickly. Claims are matched to your data, and preliminary results are presented with their limits stated.

03

Work packages and milestones

We build work packages, tasks, deliverables and measurable milestones with go/no-go points. Timelines and effort are checked against what the methods need, including characterization, sterilization and regulatory testing steps.

04

Risk register and mitigation

We list technical, regulatory, manufacturing and partner risks with likelihood, impact and a real fallback for each. Risk tables that only name risks lose points, so every entry gets a concrete contingency.

05

Commercialization and impact sections

We draft the market, route-to-use, regulatory pathway and exploitation sections from verifiable sources. Market figures are cited, never invented, and the plan names the next funding step after this grant.

06

Grant application review

An independent, reviewer-style read of your draft against the published criteria. You receive a marked-up copy, a criterion-by-criterion summary and a prioritized fix list separating serious gaps from polish.

How we work on an application

Our grant writing services follow the same three steps for every scheme.

Scope against the call

We review the funding call, your data, and your deadline, then agree in writing which sections we’ll draft, edit, or critique. We set review dates that leave time before the funder’s deadline.

Draft and test the case

We outline the application against the scoring criteria, then draft or revise sections with your technical leads. Every claim is checked against your data and cited sources, and open questions reach your team in one list.

Critique and finalize

A reviewer-style read of the full draft finds gaps between sections, such as objectives no work package delivers. We help close them, check page limits and formatting, and return final text for you to submit.

How funding applications typically arrive

A

University and SME consortium

Consortium bid on wound-healing biomaterials lacks a coherent work plan

Situation
A university group and a small biomaterials company plan a joint application on a wound-healing dressing. Each partner wrote its own sections. Objectives, work packages and budget do not line up, and nobody has tested the draft against the evaluation criteria.
How we advise
We map objectives to work packages with clear partner roles. Milestones become measurable, such as a target swelling ratio or a cytotoxicity endpoint, each with a go/no-go point. The risk register gets real fallbacks, including the effect of sterilization on the material. A reviewer-style critique then scores the draft against the published criteria.
What you receive
A restructured work plan with milestones and a timeline chart, a risk register, revised technical sections and a criterion-by-criterion critique with priority fixes.
B

Small medical device company

Small company needs technical and commercialization sections for innovation funding

Situation
A small company with promising bench data applies for innovation funding to build a working prototype. The founders describe the technology well but say little about feasibility, regulatory pathway or how the product reaches customers. The commercialization section mostly restates the technical one.
How we advise
We separate what the data already shows from what the project must prove. The technical section sets feasibility objectives with quantitative success criteria. For commercialization, we outline the likely regulatory route, customer, competing approaches and next funding step. Market figures come from cited sources, and we flag assumptions your team must confirm.
What you receive
Drafted technical and commercialization sections aligned to the scheme's criteria, a list of assumptions to verify, and a source for every market and regulatory statement.
C

Translational research group

Resubmission must answer reviewer comments without rewriting everything

Situation
A research organization's translational grant application was not funded. Reviewers praised the concept but questioned the preliminary data, the statistical plan and one partner's capacity. The team now has new results and wants to resubmit at the next deadline.
How we advise
We sort each reviewer comment into evidence gaps, design weaknesses and presentation problems. New data is placed where it answers a specific doubt. With your statistician, we tighten the analysis plan and sample size rationale, and we strengthen the partner's role. Where the scheme allows a response section, we draft point-by-point answers that are direct, not defensive.
What you receive
A comment-by-comment response matrix, revised sections with tracked changes, a draft response introduction where allowed, and a final critique against the criteria.

Illustrative scenarios. Each is a composite of common client situations, not a specific engagement.

Frequently asked questions

Which funding programs do you support?

We support applications to programs such as the US SBIR and STTR programs, Horizon Europe and EIC calls, national innovation agencies and foundations. Eligibility and rules can change between rounds, so we confirm the current call text and deadline with you at the start.

Can you promise that our application will be funded?

No. Funding decisions rest with the agency, its reviewers and its budget, and strong applications still miss out in competitive calls. We do not quote success rates. We make sure the application answers the criteria, its claims match your evidence and the work plan is credible.

Who is the author of the application?

You are. The applicant organization and its named investigators remain the authors of record and are responsible for what they submit. We draft, edit and critique with your team, and you approve every section. Some funders set rules on paid consultants or AI-assisted drafting, so we check them at the start and work within them.

What do you need from us to start?

The call text or program link, your deadline, any earlier drafts or reviewer feedback, and your key data, even if preliminary. For consortium bids, we need each partner's role and an outline budget. A technical lead who answers questions within a few days shortens timelines most.

How much time should we allow?

Allow several weeks for a full application and less for a draft review. Timing depends on the scheme, the maturity of your data, the number of partners and how fast your team reviews drafts. Consortium bids take longest because every partner must agree the plan. With only a few weeks to a deadline, a focused review of your draft is usually the realistic scope.

What happens if the application is not funded?

Many schemes return scores or reviewer comments. We analyze that feedback, separate presentation issues from real evidence gaps, and advise whether to resubmit, switch scheme or generate more data first. A resubmission then becomes focused work, not a full rewrite.

Planning an R&D funding application?

Send the funding call link and your deadline. We’ll suggest where we can help and send a written quote.

Neucite Consulting supports the preparation of funding applications; the applicant remains the author of record, and funding decisions rest solely with the funding body.